Css LLC Biohaven Pharmaceutical Holding CO Ltd. Put Options Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $33.5 Million - $35.2 Million	231,300 Added 21027.27%	232,400 $35.1 Million
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $116,396 - $204,386	-1,400 Reduced 56.0%	1,100 $161,000
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $275,200 - $357,299	2,500 New	2,500 $296,000
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $2.16 Million - $3.09 Million	-33,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $2.19 Million - $3.31 Million	33,700 New	33,700 $2.89 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.